[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-MBRX":3,"homepage-market-summary":31,"stock-news-MBRX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"MBRX","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Moleculin Biotech, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.","17","Houston, TX",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},0.4455,0.4878,0.49,0.44,0.4766,-0.0311,-6.53,705891.782507,1368,0.4563,15.75,0.1614,566043.1826515776,1.8,2600,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":154},"success",[34,42,49,55,62,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":18,"is_up":40,"sparkline":54,"date":5},"DJI","DOW JONES",51521,253,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":40,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":14,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":40,"sparkline":90,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.53,202,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.24,54.01,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",1.2,111.75,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.9,81.77,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.47,63.75,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.87,171.58,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",0.46,49.73,{"name":140,"etf":141,"change":142,"price":143,"is_up":40},"Real Estate","XLRE",1.06,41.1,{"name":145,"etf":146,"change":147,"price":148,"is_up":40},"Utilities","XLU",2.98,41.16,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",0.04,111.65,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":161,"name":162,"price":163,"change":137,"is_up":40},"QQQ","Invesco QQQ Trust",759.69,{"ticker":165,"name":166,"price":167,"change":47,"is_up":40},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":169,"name":170,"price":171,"change":172,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":174,"articles":175},12,[176,182,188,194,199,205,210,216,221,226,232,237],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6wFBVV95cUxOTVZRaTVpcmhGLTJHTnNlZ3ZHcXp3LXhkQjY4NGVMb2RnWEEzQThRal9yY01lbVI4UUk5LWx5NF9yblBsT3k2U0pJUy1yNHdGUmp4T01CTEVOSnhIRWV5WkMzckpYNE9fM3BYNW5PMWJJdjBuM1V2b3Q2RG9WNVJVd3c0MWxtTk9waXo3aXhvWEhTM2FidVpBT2Y3dURYNWZRMFZIRWpzd1ljYU54eWdwb092ZmVnRzFSMVZHd2NqR21xd3lieWNTa2w4NW5lei1qOVRVYnNIa2VTWVdEZTVHZkhvLXZWZlRiVFJz?oc=5","Tue, 06 Oct 2026 05:23:40 GMT","MBRX Stock Drops 25% As Moleculin Biotech's Interim Cancer Trial Data Falls Short Of Significance Stocktwits","Stocktwits",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNQk83ZUtrcExUaTZCVnlacGpVVGFtN3hnc0xyV2wwaGlvNnpuaV9KcE9ndlduQUZaZUhSOWs3OXVaUjhucnpqdXdubmFWc0pkOURySkNneml3X0dScjRhZ1p6bFAtV0VHRExSZ0hGQzladXdYVkJBSjlxY1BFSWFFX2ttUkNQSmdkbjRMUHVTZkpicUR1YVhwaHJYVmhWQXpYX2R2VVNBdEd3b3BYa3FxLTdpcW1tM1cwaDJocQ?oc=5","Tue, 29 Sep 2026 12:45:00 GMT","A leukemia trial finished enrolling 89 people. Full results are expected in early 2027. Stock Titan","Stock Titan",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"Moleculin Biotech CS (MBRX-Q) Stock Price and News - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMib0FVX3lxTE03M0oyaThkbXlwOHhDUUg0Q3BUb0FvMTBOUVhUdWROQ2o0Qkxka3ViS2FzODdXR3lwQWpvVWI3Z3pUc0dmZjFCT010WUp0MUQ0MkNTWDRfa3MwSm1RUEx6S0kyTUEtYXdWeVFkdHRVNA?oc=5","Fri, 02 Oct 2026 04:54:35 GMT","Moleculin Biotech CS (MBRX-Q) Stock Price and News The Globe and Mail","The Globe and Mail",{"title":195,"link":196,"pubDate":197,"description":198,"source":187},"A review found no signs of heart damage in 90 patients given a cancer drug - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxOSXpKanJESkREQ0pvSHB4bmZaMjdTS2dHYjZjSlByVDJka25qNzMxQU1jNlNQdVk0UG5NeW5zWlhmVnFreGktd2VNbS1DMWc2QnVzRS1KRzJXaXg1OGZ3Z2FuYUIyRnp5NW9aSjdkdzJiMTZnaXhUcFZaaHZ6ajNNWUQ3MDZXSFpVamk1TzhkaUxnam9KQmlmQ0dPbjV2UnRyTzV4cGM5Q3RqNm9oaldrTE5VY2c5ZGFqX0E?oc=5","Mon, 28 Sep 2026 11:00:00 GMT","A review found no signs of heart damage in 90 patients given a cancer drug Stock Titan",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Certain Pre-Funded Warrants of Moleculin Biotech, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2026. - www.marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5AFBVV95cUxOcnRxYXVwZlRkM2tWWWlsRldRTE1pMzFuSm02OGtkTHdHTDlaS1oyM3NHUDFmREV2aFFoUFJtUTUtcDZZVWpFWVBESldzY0ZFbHBqLU1VRGthdkVqN3NMSFpELVpsYVktbDAxRWtZMU9pX29wM3FVdHp1TTR4Y2lIaW14SEFzc3V0aGlqYUk3QTR1dGhFS3JvLVA1ZzB6TTFZZVVwYkdVaEFNazVoTmFQMGhoeVFLWHl0YTRqQ1BmRXRKUHBQTHJGeHI0SXFGcWMzeURoa1lwdk0wampnSFN0aGkzS0E?oc=5","Sat, 03 Oct 2026 00:22:29 GMT","Certain Pre-Funded Warrants of Moleculin Biotech, Inc. are subject to a Lock-Up Agreement Ending on 3-OCT-2026. www.marketscreener.com","www.marketscreener.com",{"title":206,"link":207,"pubDate":208,"description":209,"source":187},"A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxNM3RtNndJVElpRGRYNjRFM0RORjFNZXRoXzBYMkpGS3drbEt5SVczQ2NCenlSMVhPVnFrcXV4VkpfVUE2aDZhVnlfLTljZnJESVlYZWVXRS15YTJlUGNmQUVDaWw4aFFxWWFBMEgydk1LUnlVZkRzb2xvRmZ3MG55ZnQtQVgwU1hHX3lLVHhVRkt3OXJieVJvUHVqZ0xWZjQtQmtBdktEdnQ0Z0tmVEZqSmxXT3hsSE83QTRadGl3?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","A cancer drug may help immune cells attack pancreatic tumors, early tests suggest. Stock Titan",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"Moleculin Biotech stock reaches 89-patient MIRACLE milestone2d4f8a6b-9c3e-4f1a-b7d2-5e8c0a6f3b91 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi8AFBVV95cUxQZUpyaXVSNlltcURhaUJsRHFrVmJqam9TWXVBemxta0JQckZpTmU2c0pZWjhYUGQ5SUI1VXA2eW9xNTQtUXhvWm9JR1lWbkFIaVNRZFNyNzh1VndoVzJuUE5jUC05NHFjdDh1UXhPTUlWX1VjVzZpN1N4SDdjQmNiR0V2UXhJRzNoMGtnQjlWTjFWd0JhcW16eW44dG5hbmdWQVpfdG9wMnBKRXMtTy1mMjVJNFpCTVFTNnBNcTdSZkUyRzBzUjBacmJHdThrdndaZGVIZHNYNlVsOHIyZmhVX0o5dV9NSlRrTFd3c0p1OF8?oc=5","Mon, 05 Oct 2026 09:14:55 GMT","Moleculin Biotech stock reaches 89-patient MIRACLE milestone2d4f8a6b-9c3e-4f1a-b7d2-5e8c0a6f3b91 AD HOC NEWS","AD HOC NEWS",{"title":217,"link":218,"pubDate":219,"description":220,"source":181},"Hycroft Mining Stock Is Rallying Today – What Is Driving Trader Sentiment? - Stocktwits","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3AFBVV95cUxPa2thOXdZMC1IN245eXhjdFBkbjFUV3VwR2RTNTNpaEVNb1U4OGhxSUpodnUtRWN0NnpYbnpNa05fYVpsdUpsTkh0dktabzBnWllIR3UwaWZybVo0MlozQ0sxZzRhdHhMeVlTdEhXMmJ5OWZmbmdYZUJXdTd0ZEotMmZFSGhaZnlzOUNSZ0g0V0lDV1E0bVVFNUlWbFdrTUZHajdBWWw0Y0VLdTZvamZVQTd2TnFLQ0psSW9ldEZpVHhSQjVBUkZUeHhxX24wQVVFRTE0dnlUcEhDYTJX?oc=5","Sun, 04 Oct 2026 14:59:38 GMT","Hycroft Mining Stock Is Rallying Today – What Is Driving Trader Sentiment? Stocktwits",{"title":222,"link":223,"pubDate":224,"description":225,"source":215},"Moleculin Biotech stock fell 2.10 percent on October 5 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxOQWZ6R2MtYW40Q2tIaFBNUFJnVjhOVkF1NERSd2FJMTNGX09Zb05hdDh3bk4zT21KSmxZNGpNbVdiM0g3cWxiaFI0aEpDc2FFZkRKTXh6UGFMNjZRY2lwd2FKaXgtbnJkUkVmaFRjZ18zNjBFeFh0Qnluak9tVGYyS2Q2SG9GTnFMZFphUWUtRXhnUU1tQm5IUXo4NDhRZWFmdGN6MU80d0dPNmZQVExOXzhYVmdkU01M?oc=5","Tue, 06 Oct 2026 08:53:26 GMT","Moleculin Biotech stock fell 2.10 percent on October 5 AD HOC NEWS",{"title":227,"link":228,"pubDate":229,"description":230,"source":231},"Moleculin Biotech Updates Investors With New Presentation - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisAFBVV95cUxQb1RZOXUtLXN0bHk2SG9KZ194c01vYllMMEpIbmtZLUxoUFROTTgyVjZDUWhMN1hHWUR5WHJmNUhSbVhXbXRyUjg3aFpPeEJKVHhzbmNhcWh2M0EwQjRJT3RaMEpYRHBobW9Ka0VjUV9SVUd0VTZ0cDdpR0hpQnFlVGZTc2ppckh1ekF5VVNOYkJOSXpWVnFxQzY2cjVuRnJJb0d1UEJPY01Yekc5N09EUA?oc=5","Mon, 05 Oct 2026 13:06:02 GMT","Moleculin Biotech Updates Investors With New Presentation TipRanks","TipRanks",{"title":233,"link":234,"pubDate":235,"description":236,"source":231},"Moleculin Completes Enrollment in Pivotal AML Trial - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxNUkE5MnBJV0V3NFhicEg0UV9vektwZ3dKMlR4b0F3VVVLaWZkTXMydnk5TkwtNUNkdGt1d051ZmhFOTU5UWRKdmVtVGJIUnM0aDRVanBnUEtOUDNIV25IQjFUQ1hERV9VRGdYZHFWeUNwaHlURFFScmhiUE5nUFFGU0lIN1c0REN5bTN6VHlYLS1oMTdqWmNFZ0N3eS1sN1dFZXFUT1B3?oc=5","Tue, 29 Sep 2026 13:37:06 GMT","Moleculin Completes Enrollment in Pivotal AML Trial TipRanks",{"title":238,"link":239,"pubDate":240,"description":241,"source":231},"Moleculin Highlights Annamycin Cardiac Safety in New Analysis - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxNTjhtN2lPVXhXU0JTOVJERGM2b3ZoMjJXdmRpNXM1Wlg3SmZpeF9LblBjRlhDYjZ4V085Z3lhZjF6UXNBMVR6QVBhemxpaGZaOWd0V2N3THZEQjJMQTdUQVJNUnNSVExCTWpWWmdxQTNXV1BhRkRDU2dmb0hJV2ZZOHRIQzNTOVZzOG1RYnlJZGJJbDU5MHBPU2VYVmRhZHFPOEdNbEJrTmdxV3h1enFWMTg1cw?oc=5","Mon, 28 Sep 2026 11:29:26 GMT","Moleculin Highlights Annamycin Cardiac Safety in New Analysis TipRanks"]